Project Grant R01AG087091

Award Date 5/15/24
Completion Date 2/28/29
Dollars Obligated $2.2M
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
Philadelphia, PA 19104, USA
Similar Awards
This $334,788 Project Grant awarded by the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the impact of recent revisions to the Medicare home health payment system (Patient-Driven Groupings Model or PDGM) on access, care delivery, and outcomes for community-living Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The 2-year study, starting September 1, 2023, will leverage Medicare claims, home health assessment, and agency data to:...
This $1,623,380 Project Grant award from the National Institute on Aging (CFDA 93.866 Aging Research) supports a study by Cedars-Sinai Medical Center examining the impact of physician, hospital, and skilled-nursing facility factors related to geriatric care on days spent at home among persons with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). The study aims to (1) determine the effect of physician factors like geriatric subspecialty certification and health system...
This federal Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) provides $2,278,636.00 to The Trustees of the University of Pennsylvania to characterize and evaluate different models of clinician care for nursing home residents with Alzheimer's disease and related dementias (ADRD). The project aims to survey a nationally representative sample of nursing home clinicians, link this data to Medicare claims and nursing home records, and assess the outcomes and...
This federal Project Grant award of $608,731, provided by the National Institute on Aging (CFDA 93.866 Aging Research), supports a research project focused on understanding the impact of Medicare and Medicaid financial policies on post-acute and long-term care for persons living with dementia. The key products and services to be delivered under this 5-year grant, awarded to Brown University starting in September 2024, include leveraging Medicare claims and clinical assessment data to analyze how...
This $121,209 National Institute on Aging project grant will support research assessing the impact of primary care structural capabilities on hospitalizations among older adults with dementia. Specifically, the grantee will analyze cross-sectional data from 2018-2019 to describe structural capabilities like care coordination, electronic health records, and community integration in primary care practices employing nurse practitioners to serve Medicare beneficiaries with Alzheimer's disease and...
This $1,306,862 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a study investigating the relationship between REIT (real estate investment trust) investments in nursing homes and the quality of end-of-life care for residents with Alzheimer's disease and related dementias. The project will construct a nationally representative database of nursing home residents with ADRD using Medicare claims and other data, and analyze the impact of REIT...
This $2,497,615 federal Project Grant award, funded by the National Institute on Aging under the Aging Research program (CFDA 93.866), aims to evaluate the impact of new Medicare home health agency (HHA) payment policies on healthcare utilization and outcomes for Medicare beneficiaries with Alzheimer's disease and related dementias (ADRD). The project has three key objectives: 1) characterizing changes in the ADRD beneficiary population eligible for HHA services, 2) evaluating the effect of...
This Project Grant award, worth $2,112,538.00, was provided by the National Institute on Aging under the Aging Research federal grant program (CFDA 93.866) to The Johns Hopkins University. The project aims to evaluate the effectiveness of integrated Dual Eligible Special Needs Plans (D-SNPs) in providing home and community-based services, prescription drug quality, and long-term outcomes for dual eligible individuals with Alzheimer's disease and related dementias. The study will analyze...
This federal Project Grant award of $1,846,173 from the National Institute on Aging's Aging Research program (CFDA 93.866) supports research to understand the impact of Medicare Advantage (MA) coverage on healthcare utilization and intergenerational transfers among patients with Alzheimer's disease and related dementias (ADRD). The 5-year project, running from August 2024 to April 2029, will examine differences in potentially preventable hospitalizations, burdensome transfers, and post-discharge...
This $243,000 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will support a 5-year study to identify factors associated with and barriers/facilitators to routine deprescribing of potentially inappropriate medications (PIMs) among older adults with Alzheimer's disease and related dementias (ADRD) receiving home health care. The study has two main aims: 1) Use a mixed methods approach to analyze existing data and engage stakeholders to further develop a...

ALIGNING INCENTIVES ACROSS MEDICAID AND MEDICARE FOR NURSING HOME RESIDENTS WITH AD/ADRD - PROJECT SUMMARY OVER ONE MILLION PEOPLE LIVE IN U.S. NURSING HOMES, TWO-THIRDS OF WHOM HAVE ALZHEIMER'S DISEASE AND RELATED DEMENTIAS (AD/ADRD) AND ONE-QUARTER OF WHOM ARE DUALLY ELIGIBLE FOR MEDICAID AND MEDICARE. DUAL-ELIGIBLE RESIDENTS WITH AD/ADRD OFTEN RECEIVE LOW-QUALITY NURSING HOME CARE AT HIGH COSTS, DUE IN PART TO THE CONFLICTING FINANCIAL INCENTIVES CREATED BY MEDICAID AND MEDICARE. NURSING HOMES RELY ON GENEROUS MEDICARE PAYMENTS FOR SHORT SKILLED NURSING HOME STAYS. AT THE SAME TIME, NURSING HOMES CARE PREDOMINANTLY FOR MEDICAID-FUNDED LONG-STAY RESIDENTS, STAYS FOR WHICH MEDICAID PAYMENT OFTEN DOES NOT COVER THE COSTS. THIS CREATES CONFLICTING INCENTIVES FOR NURSING HOMES AND FRAGMENTED CARE FOR DUAL-ELIGIBLE RESIDENTS. THIS INCLUDES HIGH RATES OF POTENTIALLY AVOIDABLE HOSPITALIZATIONS AS NURSING HOMES SHIFT THE HIGH COSTS OF CARING FOR A SICKER RESIDENT TO A MEDICARE-PAID HOSPITALIZATION. IT ALSO CAUSES NURSING HOME RESIDENTS TO CYCLE BETWEEN THE NURSING HOME AND HOSPITAL, INCREASING THE USE OF MEDICARE-COVERED SKILLED NURSING HOME STAYS ON RETURN TO THE NURSING HOME, WHICH MAY BE UNNECESSARY AND COSTLY TO MEDICARE. ONE POTENTIAL SOLUTION TO THESE CONFLICTING INCENTIVES IS FOR STATES TO INCREASE MEDICAID PER-DIEM RATES, WHICH WOULD DECREASE THE MEDICAID-MEDICARE PAYMENT DIFFERENTIAL. THIS WOULD BETTER ALIGN INCENTIVES FOR NURSING HOMES TO PROVIDE HIGHER-ACUITY CARE FOR RESIDENTS RATHER THAN TRANSFERRING THEM TO THE HOSPITAL. IT WOULD ALSO ELIMINATE THE INCENTIVE TO PROVIDE MEDICARE-FUNDED SKILLED CARE DUE ONLY TO THE HIGHER PROFITABILITY OF THESE STAYS, RATHER THAN THE POTENTIAL CLINICAL BENEFIT TO RESIDENTS. ANOTHER POTENTIAL SOLUTION IS TO USE GLOBALLY CAPITATED PAYMENTS FOR NURSING HOME STAYS, WHICH HOLD NURSING HOMES FINANCIALLY ACCOUNTABLE FOR SPENDING. A PROMINENT EXAMPLE OF THIS IS MEDICARE-ESTABLISHED INSTITUTIONAL SPECIAL NEEDS PLANS (I-SNPS) FOR DUAL-ELIGIBLE NURSING HOME RESIDENTS. I-SNPS ARE SPECIALIZED MEDICARE ADVANTAGE PLANS THAT BEAR RISK FOR ALL MEDICARE-COVERED SPENDING FOR NURSING HOME RESIDENTS AND AS A RESULT, MAY INCENTIVIZE NURSING HOMES TO INVEST IN CAPABILITIES TO BETTER MANAGE HIGH-ACUITY RESIDENTS IN THE NURSING HOME RATHER THAN IN THE HOSPITAL, ALLOWING NURSING HOMES TO HIGHER-INTENSITY SKILLED CARE WITHOUT A PRECEDING HOSPITALIZATION. DESPITE THE PROMISE OF THESE APPROACHES AND URGENT NEED TO DECREASE FRAGMENTATION, LITTLE IS KNOWN ABOUT HOW TO REFORM NURSING HOME PAYMENT TO ACCOMPLISH THIS. THIS IS PARTICULARLY IMPORTANT FOR INDIVIDUALS WITH AD/ADRD GIVEN THEIR LARGE NUMBERS IN NURSING HOMES, HIGH LIKELIHOOD OF BEING DUALLY ENROLLED IN MEDICARE AND MEDICAID, THE HIGH COSTS OF CARE, AND POOR OUTCOMES FROM UNNECESSARY AND BURDENSOME TRANSITIONS OF CARE. OUR OVERALL OBJECTIVE IS TO EXAMINE WAYS TO ALIGN THE HISTORICALLY MISALIGNED INCENTIVES CREATED BY THE MEDICARE AND MEDICAID PROGRAMS IN NURSING HOMES AND, IN DOING SO, SUBSTANTIVELY IMPROVE CARE FOR RESIDENTS WITH AD/ADRD. THESE RESULTS WILL PROVIDE CRITICAL AND RIGOROUS EVIDENCE ON HOW TO INTEGRATE MEDICAID- AND MEDICARE-FUNDED CARE FOR DUAL-ELIGIBLE NURSING HOME RESIDENTS WITH AD/ADRD AND IMPROVE OUTCOMES. THESE RESULTS WILL INFORM CURRENT POLICY DEBATES AND FUTURE DIRECTIONS OF ONGOING INTEGRATION EFFORTS.

Posted 5/6/24, 12:00 AM